Cytori Completes Enrollment In International Breast Cancer Reconstruction Study; Interim Data To Be Presented Dec. 12
Posted by: DrugsNews on: 18 Nov, 2009
Cytori Completes Enrollment In International Breast Cancer Reconstruction Study; Interim Data To Be Presented Dec. 12
Cytori Therapeutics (NASDAQ:CYTX) completed enrollment in a 70-patient, international breast cancer reconstruction study, RESTORE 2. The study is evaluating the use of cell-enriched fat grafting to restore functional and cosmetic deformities in women who have undergone partial mastectomy for early breast cancer.
Read more about Cytori Completes Enrollment In International Breast Cancer Reconstruction Study; Interim Data To Be Presented Dec. 12
| Indian Pharmacy Online! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Random Posts
Related posts:
- $2.95 Million Government Breast Reconstruction Funding Gives New Benefit To Breast Cancer Survivors, Australia
- Promising Results Reported In Cell-Enriched Breast Reconstruction Trial
- Data from a Phase I/II Study Presented at the 32nd San Antonio Breast …
